Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Real-time Quote. Real-time Tradegate - 10/17 04:54:24 pm
118.426 EUR   -0.98%
10:18a BAYER : foundations bring tech pioneers physicians and social entrep..
10/14DJBAYER : Unloads Assets to Aid Deal -- WSJ
10/13 BASF CEO says to look at more seed M&A after Bayer deal
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Analysis summary4-Traders Strategies

Franck Morel

Founder and CEO
share with twitter share with LinkedIn share with facebook
share via e-mail

A technical turn-around configuration

Strategy published on 10/07/2016 | 14:32
long trade
Expirée le 10/22/2016
Entry price : 90.25€ | Target : 104€ | Stop-loss : 87.9€ | Potential : 15.24%
Bayer AG reflects attractive technical aspects that could allow investors to expect a trend reversal over the medium term.
Investors have an opportunity to buy the stock and target the € 104.
Summary
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • The share is getting closer to its long-term support in weekly data, at EUR 85.33, which offers good timing for buyers.
  • The close medium term support offers good timing for purchasing the stock.
  • The company returns high margins, thereby supporting business profitability.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses
  • The underlying tendency is negative on the weekly chart below the resistance at 102.75 EUR
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (€)
Sales 2017 48 368 M
EBIT 2017 9 231 M
Net income 2017 5 396 M
Debt 2017 12 235 M
Yield 2017 2,32%
P/E ratio 2017 19,67
P/E ratio 2018 17,76
EV / Sales 2017 2,30x
EV / Sales 2018 2,19x
Capitalization 98 903 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart BAYER
Duration : Period : Day
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Duration : Period : Week
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders